-
Predictive value of q waves in inferior leads for the diagnosis of old inferior wall myocardial infarction
Zameer Abedin, Jennifer Dochee, David Gough, Moeen Abedin, Tariq Siddiqi, Debabrata Mukherjee, Zuber D Mulla, Zainul Abedin
Research Article: Clinical Investigation
-
Predictive value of q waves in inferior leads for the diagnosis of old inferior wall myocardial infarction
Zameer Abedin, Jennifer Dochee, David Gough, Moeen Abedin, Tariq Siddiqi, Debabrata Mukherjee, Zuber D Mulla, Zainul Abedin
Research Article: Clinical Investigation
-
Predictive value of q waves in inferior leads for the diagnosis of old inferior wall myocardial infarction
Zameer Abedin, Jennifer Dochee, David Gough, Moeen Abedin, Tariq Siddiqi, Debabrata Mukherjee, Zuber D Mulla, Zainul Abedin
Research Article: Clinical Investigation
-
Predictive value of q waves in inferior leads for the diagnosis of old inferior wall myocardial infarction
Zameer Abedin, Jennifer Dochee, David Gough, Moeen Abedin, Tariq Siddiqi, Debabrata Mukherjee, Zuber D Mulla, Zainul Abedin
Research Article: Clinical Investigation
-
Predictive value of q waves in inferior leads for the diagnosis of old inferior wall myocardial infarction
Zameer Abedin, Jennifer Dochee, David Gough, Moeen Abedin, Tariq Siddiqi, Debabrata Mukherjee, Zuber D Mulla, Zainul Abedin
Research Article: Clinical Investigation
-
Predictive value of q waves in inferior leads for the diagnosis of old inferior wall myocardial infarction
Zameer Abedin, Jennifer Dochee, David Gough, Moeen Abedin, Tariq Siddiqi, Debabrata Mukherjee, Zuber D Mulla, Zainul Abedin
Research Article: Clinical Investigation
-
Predictive value of q waves in inferior leads for the diagnosis of old inferior wall myocardial infarction
Zameer Abedin, Jennifer Dochee, David Gough, Moeen Abedin, Tariq Siddiqi, Debabrata Mukherjee, Zuber D Mulla, Zainul Abedin
Research Article: Clinical Investigation
-
Predictive value of q waves in inferior leads for the diagnosis of old inferior wall myocardial infarction
Zameer Abedin, Jennifer Dochee, David Gough, Moeen Abedin, Tariq Siddiqi, Debabrata Mukherjee, Zuber D Mulla, Zainul Abedin
Research Article: Clinical Investigation
-
Questions for stem cell transplant in peripheral T-cell non-Hodgkins lymphomas
Jasmine Zain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Questions for stem cell transplant in peripheral T-cell non-Hodgkins lymphomas
Jasmine Zain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Questions for stem cell transplant in peripheral T-cell non-Hodgkins lymphomas
Jasmine Zain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Questions for stem cell transplant in peripheral T-cell non-Hodgkins lymphomas
Jasmine Zain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Questions for stem cell transplant in peripheral T-cell non-Hodgkins lymphomas
Jasmine Zain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Questions for stem cell transplant in peripheral T-cell non-Hodgkins lymphomas
Jasmine Zain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Questions for stem cell transplant in peripheral T-cell non-Hodgkins lymphomas
Jasmine Zain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Questions for stem cell transplant in peripheral T-cell non-Hodgkins lymphomas
Jasmine Zain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ecallantide for the treatment of acute attacks of hereditary angioedema due to C1-inhibitor deficiency
Jonathan Bernstein, Joseph Biedenkapp
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ecallantide for the treatment of acute attacks of hereditary angioedema due to C1-inhibitor deficiency
Jonathan Bernstein, Joseph Biedenkapp
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ecallantide for the treatment of acute attacks of hereditary angioedema due to C1-inhibitor deficiency
Jonathan Bernstein, Joseph Biedenkapp
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ecallantide for the treatment of acute attacks of hereditary angioedema due to C1-inhibitor deficiency
Jonathan Bernstein, Joseph Biedenkapp
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ecallantide for the treatment of acute attacks of hereditary angioedema due to C1-inhibitor deficiency
Jonathan Bernstein, Joseph Biedenkapp
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ecallantide for the treatment of acute attacks of hereditary angioedema due to C1-inhibitor deficiency
Jonathan Bernstein, Joseph Biedenkapp
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ecallantide for the treatment of acute attacks of hereditary angioedema due to C1-inhibitor deficiency
Jonathan Bernstein, Joseph Biedenkapp
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ecallantide for the treatment of acute attacks of hereditary angioedema due to C1-inhibitor deficiency
Jonathan Bernstein, Joseph Biedenkapp
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation